1) pulmonary capillary blood volume
肺毛细血管床容量
1.
Alveolar capillary membane diffusing capacity and pulmonary capillary blood volume in normal adults;
正常人的肺泡毛细血管膜弥散能力和肺毛细血管床容量
2.
AIM: To compare the effect of the membrane diffusing capacity (Dm) and pulmonary capillary blood volume (Vc) on carbon monoxide diffusing capacity (D LCO) pre and post-operatively.
目的 :比较肺减容手术前、后肺膜弥散量 (Dm)和肺毛细血管床容量 (Vc)对一氧化碳弥散量 (DLCO)的影响 。
2) pulmonary capillary blood volume
肺泡毛细血管床容量
3) Pulmonary capillary volume
肺血管床容量
4) pulmonary capillary blood flow
肺毛细血管有效血流量
1.
[Methods] Pulmonary ventilatory function, diffuse function, pulmonary capillary blood flow (CO) of 54 patients with ILD were measured.
方法观察弥漫性肺间质病变54例的肺通气功能、弥散功能、肺毛细血管有效血流量、血气变化及肺CT影像学改变,并按发病时间长短分3组观察肺活量(vital capacity,VC)、一氧化碳弥散量(diffusing capacity of the lung for carbon monoxide,Dlco)、肺毛细血管有效血流量(pulmonary capillary blood flow,CO)异常检出率。
6) Pulmonary capillary wedge pressure
肺毛细血管楔压
1.
Methods Pulmonary capillary wedge pressure(PCWP)was determined by Swan-Ganz catheter in 38 patients with severely acute heart failure who exacerbated after routine treatment at half an hour and 48 hours.
5h和48h,记录肺毛细血管楔压(PCWP),同步采用干式快速免疫荧光定量分析法检测血浆中的BNP水平,然后根据情况选用各种药物治疗。
2.
Pulmonary capillary wedge pressure(PCWP),pulmonary arterial pressure(PAP) and cardiac index(CI) were measured in all patients at different time points as immediately before drug administration,and 15 min,1 h,3 h and 24 h after drug administration.
分别在用药前、用药后15min、1h、3h、24h测量并记录肺毛细血管楔压(PCWP)、肺动脉压(PAP)和心脏排血指数(CI)。
补充资料：指甲床毛细血管镜检查
指甲床毛细血管镜检查
用解剖显微镜观察指甲床内毛细血管形态，数量、血液充盈度，以及有无毛细血管周围出血的一种方法。借以判断机体末梢循环的状态和毛细血管功能状况。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条